Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
about
Novel mouse model reveals distinct activity-dependent and -independent contributions to synapse developmentAcetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy.Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patientsAdverse neuropsychiatric effects of antimalarial drugs.Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis
P2860
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@ast
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@en
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@nl
type
label
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@ast
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@en
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@nl
prefLabel
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@ast
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@en
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@nl
P2093
P1433
P1476
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
@en
P2093
Clint A Rosenfeld
Joseph G Potian
Joseph J McArdle
Kathleen M Coakley
Kormakur Hognason
Lawrence C Sellin
Lester G Sultatos
Mary C Quinones-Lopez
P304
P356
10.1016/J.NEUROPHARM.2005.06.011
P577
2005-08-02T00:00:00Z